For real world
clinical practice
CPD 0.5
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:30 minutes
CPD 0.5
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:30 minutes
CPD 1.0
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:1 hour
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:30 minutes
CPD 1.0
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:1 hour
CPD 0.5
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:30 minutes
CPD 0.5
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:30 minutes
CPD 0.5
Free
Cutaneous T-Cell Lymphomas (CTCL)
This is a Module from the Course
By MedShr Dermatology Editor
Expected time:30 minutes
CPD 0.5
Free
Deploying Data in the Fight Against Cancer
This is a Module from the Course
By Prof Mark Lawler
Expected time:30 minutes
CPD 0.5
Free
Dermatomyositis
This is a Module from the Course
By MedShr Rheumatology Editor
Expected time:30 minutes
CPD 0.25
Free
Diabetes
This is a Module from the Course
By MedShr Global Health Editor
Expected time:15 minutes
CPD UK
Free
Diabetes
This is a Module from the Course
By MedShr Global Health Editor
Expected time:1 hour
CPD UK
Free
Dislipidemia
This is a Module from the Course
By MedShr Global Health Editor
Expected time:30 minutes
CPD 0.5
Free
Do we need a DOAC versus PFO closure randomized clinical trial?
This is a Module from the Course
By John D Carroll, MD
Expected time:30 minutes
CPD 0.25
Free
Do we need a DOAC versus PFO closure randomized clinical trial?
Expected time:15 minutes
CPD UK
Free
Dyslipidaemia
This is a Module from the Course
By MedShr Global Health Editor
Expected time:1 hour